✦ LIBER ✦

A case in point: exclusions and replacements for exclusions after randomization in clinical trials

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P42 Blinding and exclusions after random

✍ Kenneth F. Schulz; David A. Grimes; Douglas G. Altman; Richard J. Hayes 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Impact of active and passive exclusions

✍ Martin Hjorth; Erik Holmberg; Stig Röder; Jan Westin; for the Myeloma Group of W 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 709 KB

End-Point Interpretation in Clinical Tri

✍ Lemuel A. Moyé 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 122 KB

A Targeted Home- and Center-Based Exerci

✍ Mary P. Galea; Pazit Levinger; Noel Lythgo; Chris Cimoli; Robert Weller; Elizabe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 108 KB

TCT-119: Reasons for Exclusion, Treatmen

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 151 KB

A prospective randomized trial of triage

✍ Peter A. McCullough; William W. O’Neill; Mariann Graham; Robert J. Stomel; Felix 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 157 KB